Las Condes 26 03

50 / 164

310
10. Ministerio de Salud, Chile. (2012). Primer informe de Registros
PoblacionalesdeCáncerdeChile,quinquenio2003-2007,http://
RPC%20CHILE%202003-2007,%20UNIDAD%20VENT,%20
DEPTO.EPIDEMIOLOGIAMINSAL,13.04.2012(2).pdf
11. Ministerio de Salud de Chile. Encuesta Nacional de Salud
2009-2010.
12.
proteccion/g_tabaco/situacionenchile.html
13. Clavero, JM. Estado actual del tratamiento del Cáncer
Pulmonar. Rev Med Clin Condes 2013; 24(4) 611-625.
14. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (Eds):
World Health Organization Classification of Tumors. Pathology
and Genetics of Tumours of the Lung, Pleura, Thymus and Heart.
IARC Press: Lyon 2004.
15. Goldstraw P, Crowley JJ. The International Association for the
Study of Lung Cancer International staging project on lung
cancer. J Thorac Oncol 2006; 1: 281-286.
16. Pao W, Girard N: New driver mutations in non-small-cell lung
cancer. Lancet Oncol 12 (2): 175-80, 2011.
17. Hirsch FR, Jänne PA, Eberhardt WE, Cappuzzo F, Thatcher N,
et al. Epidermal Growth Factor Receptor Inhibition in Lung
Cancer: Status 2012. J Thorac Oncol 2013; 8(3): 373–384.
18. Mok TS, Wu YL, Thongprasert S, et al.: Gefitinib or carboplatin-
paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361
(10): 947-57, 2009.
19. Travis, W.D. et al. International association for the study of
lung cancer/american thoracic society/european respiratory
society international multidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol 2011, 6(2): 244–285.
20. Lindeman NI, Cagle PT, Beasley MB, et al. Molecular Testing
Guideline for Selection of Lung Cancer Patients for EGFR and
ALK Tyrosine Kinase Inhibitors: Guideline from the College of
American Pathologists, International Association for the Study
of Lung Cancer, and Association for Molecular Pathology. J
Thorac Oncol. 2013;8(7):823-59.
21. Berg CD et al. Reduced lung-cancer mortality with
low-dose computed tomographic screening. N Engl J Med
2011;365;395–409.
22. Sabue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi
T, et al. Screening for Lung Cancer With Low-Dose Helical
Computaed Tomography: Anti-LungCancer Association Project.
J Clin Oncol 2002 20:911-920
23. Henschke, C.I. et al.Screening for lung cancer: the early lung
cancer action approach. Lung Cancer 2001, 35(2): 143–148.
24. Laurie SA, Kenneth KNG, Rosenzweig K, Ginsberg RJ. Treatment
of Local and Locoregional Non-Small Cell Lung Cancer . In Lung
Cancer. Ed Robert J Ginsberg Pmph Bc Decker, 2002, 101-119.
25. Manser R, Wright G, Hart D, Byrnes G, Campbell D, Wainer Z, Tort
S. Surgery for local and locally advanced non-small cell lung
cancer. Cochrane Database of Systematic Reviews 2005, Issue
1. Art. No.: CD004699. DOI: 10.1002/14651858.CD004699.
pub2
26. Lung Cancer Study Group, Ginsberg RJ, Rubinstein LV.
Randomized trial of Lobectomy versus limited resection for
T1N0 non-small cell ling cáncer. Ann Thorac Surg 1995;60:
615-623.
27. McKenna RJ. Lobectomy by video-assisted thoracic surgery with
mediastinal node sampling for lung cancer. J Thorac Cardiovasc
Surg 1994; 107:879-882.
28. Detterbeck FC, Antonicelli A, Okada M. Results of Video-
Assisted techniques for resection of Lung cancer. Pass HI, Ball
D, Scagliotti GV (eds) The IASLC Multidisciplinary Approach to
Thoracic Oncology. Aurora, CO: International Association for the
Study of Lung Cancer; 2014; 385-393.
29. Shaw JP, Dembitzer FR, Wisnivesky JP, Litle VR, Weiser TS, Yun J,
Chin C, Swanson SJ. Video-Assisted Thoracoscopic Lobectomy:
State of the Art and Future Directions. Ann Thorac Surg
2008;85:705-709.
30. Scott WJ, Allen MS, Darling G MD, Meyers B MD, Decker PA , et al.
Videoassisted thoracic surgery versus open lobectomy for lung
cancer: A secondary analysis of data from the American College
of Surgeons Oncology Group Z0030 randomized clinical trial. J
Thorac Cardiovasc Surg 2010;139:976-83.
31. Cattaneo SM, Park, BJ, Wilton AS, Seshan VE, Bains MS, Downey
RJ, Flores RM, Rizk N, MD, Rusch VW. Use of Video-Assisted
Thoracic Surgery for Lobectomy in the Elderly Results in Fewer
Complications. Ann Thorac Surg 2008;85:231–6.
32. McKenna RJ, Houck W, Fuller CB. Video-Assisted Thoracic
Surgery Lobectomy: Experience With 1,100 Cases. Ann Thorac
Surg 2006;81:421-426.
33. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K. Survival
following lobectomy vs limited resection for stage I lung cancer:
a meta-analysis. British Journal of Cancer (2005) 92, 1033 –
1037
34. R. Rami-Porta R, Tsuboi M. Sublobar resection for lung cáncer.
Eur Respir J 2009; 33: 426–435
35. Higashima M, Kodama K, Takami K, Higaki N, Nakayama T, H.
Intraoperative lavage cytologic analysis of surgical margins in
patients undergoing limited surgery for lung cancer. J Thorac
Cardiovasc Surg 2003;125:101.
36. Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H,
Maeda H, Matsuda H. Optimal distance of malignant negative
margin in excision of nonsmall cell lung cancer: a multicenter
prospective study . Ann Thorac Surg 2004; 77:415-20.
37. Schuchert MJ, Pettiford BL, Pennathur A, Abbas G, Awais O, et
al. Anatomic segmentectomy for stage I non–small-cell lung
cancer: Comparison of videoassisted thoracic surgery versus
open approach. J Thorac Cardiovasc Surg 2009,138:1318-25.
38. Jett JR, Horeweg N, de Koning HJ. Screening fot Lung Cancer.
Pass HI, Ball D, Scagliotti GV (eds) The IASLC Multidisciplinary
Approach to Thoracic Oncology. Aurora, CO: International
Association for the Study of Lung Cancer; 2014; 80-88.
39. Pastis N, Bonifazi M, Gasparini S, Silvestri GA. Diagnostic
workup for suspected lung cancer confined to the chest.Pass HI,
Ball D, Scagliotti GV (eds) The IASLC Multidisciplinary Approach
to Thoracic Oncology. Aurora, CO: International Association for
the Study of Lung Cancer; 2014; 335-344.
[REV. MED. CLIN. CONDES - 2015; 26(3) 302-312]